Manohar K. Raheja - Mar 11, 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role: EVP, Research & Development
Signature: /s/ Jeremy Hayden, Attorney-in-Fact for Manohar K. Raheja
Stock symbol: SGHT
Transactions as of: Mar 11, 2025
Transactions value $: $53,250
Form type: 4
Date filed: 3/13/2025, 09:51 PM
Previous filing: Dec 9, 2024
Next filing: May 21, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGHT	Common Stock	Award	$0	+24K	+21.62%	$0.00	135K	Mar 11, 2025	Direct	F1
transaction	SGHT	Common Stock	Purchase	$27.3K	+10K	+7.41%	$2.73	145K	Mar 12, 2025	Direct	F2
transaction	SGHT	Common Stock	Purchase	$26K	+10K	+6.9%	$2.60	155K	Mar 13, 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in four equal annual installments commencing January 15, 2026 and continuing through January 15, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the greater of (i) the closing price of the Common Stock on the grant date, which was March 11, 2025, or (ii) $5.00, such that the total number of shares of Common Stock underlying the grant of RSUs would not exceed 24,000. The RSUs have no expiration date.
F2	Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $2.70 to $2.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in four equal annual installments commencing January 15, 2026 and continuing through January 15, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the greater of (i) the closing price of the Common Stock on the grant date, which was March 11, 2025, or (ii) $5.00, such that the total number of shares of Common Stock underlying the grant of RSUs would not exceed 24,000. The RSUs have no expiration date.

Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $2.70 to $2.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.